Found this on Stockhouse front page advertising
Stockhouse Dealroom - Your Gateway to High-Potential Investment Opportunities
How Stockhouse Dealroom Works:
Investors can browse Private Placements from Public Companies and Pre-IPO offerings typically priced below market value with an attractive opportunity for upside at maturity. Investor can access company executives, reasons to invest, financials and more.
What you can do with Dealroom:
Investors can easily research and digest all the relevant material required to make an informed investment decision. The individual deals outline reasons to invest, company milestones and highlights, financials, investment terms, company contact details, and more.
Theralase® Technologies
Raising $3.5 to $5.3 million CAD
Healthcare
Theralase® is focused on commercialization of next generation Photo Dynamic Compounds (“PDCs”) for the treatment Non-Muscle Invasive Bladder Cancer (“NMIBC”)
- Multi-billion dollar opportunity as bladder cancer is the 10th most common cancer in the world (6th in men)
- Best-in-class treatment for NMIBC (according to interim clinical data)
- Investment opportunity open to all investors
terms
$0.22 CAD per Unit (1 full share + 1 full share warrant at $0.28 CAD for 5 years)